LogicBio Therapeutics, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|
| Revenue | $5.4M | $3.5M | — | — | — |
| Operating income | −$39.0M | −$31.5M | −$41.0M | −$17.9M | −$5.9M |
| Net income | −$40.0M | −$32.6M | −$40.1M | −$17.6M | −$5.8M |
| Total assets | $62.8M | $80.6M | $55.7M | $82.9M | $26.2M |
| Total liabilities | $32.0M | $19.2M | $13.4M | $2.7M | $1.7M |
| Equity | $30.7M | $61.4M | $42.3M | $80.2M | −$8.6M |
| EPS (diluted) | — | — | — | — | — |
| Shares out. | 32.0M | 23.3M | 22.3M | 22.2M | 1.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2021- Operating margin
- −720.6%
- Net margin
- −739.9%
- Return on equity
- −130.3%
- Return on assets
- −63.8%
- Return on capital (ROCE)
- −90.3%
- Liabilities / assets
- 51.0%
- Debt / equity
- 1.04×
- Book value / share
- $0.96
- Revenue growth (YoY)
- 56.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2021- Altman Z″ (distress)
- -6.67distress
- Accruals / assets
- −33.5%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Kay Mark ADirector | Nov 16, 2022 | D | 784,557 | — |
| Enyedy Mark JDirector | Nov 16, 2022 | D | 2,921 | — |
| Wyzga Michael SDirector | Nov 16, 2022 | D | 3,141 | — |
| Chereau FredericOfficer — President, CEO | Nov 16, 2022 | D | 253,811 | — |
| Moscicki Richard ADirector | Nov 16, 2022 | D | 3,916 | — |
| Chen LeonDirector | Nov 16, 2022 | D | 22,333 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsNov 16, 2022
- Results of operationsNov 14, 2022
- Other material eventOct 20, 2022
- Entered a material agreementOct 7, 2022
- Entered a material agreement · Regulation FD disclosure · Other material eventOct 3, 2022
- Director / officer changeSep 23, 2022
- Delisting / listing-standard noticeSep 20, 2022
- Director / officer changeSep 16, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 14, 2023
- SC 13D/AFeb 10, 2023
- 15-12GNov 29, 2022
- EFFECTNov 18, 2022
- 4FORM 4 SUBMISSIONNov 17, 2022
- 4FORM 4 SUBMISSIONNov 17, 2022
- 4FORM 4 SUBMISSIONNov 17, 2022
- 4FORM 4 SUBMISSIONNov 17, 2022
- 4FORM 4 SUBMISSIONNov 17, 2022
- 4FORM 4 SUBMISSIONNov 17, 2022
- 4FORM 4 SUBMISSIONNov 17, 2022
- 4FORM 4 SUBMISSIONNov 17, 2022
- 4FORM 4 SUBMISSIONNov 17, 2022
- 4FORM 4 SUBMISSIONNov 17, 2022
- 4FORM 4 SUBMISSIONNov 17, 2022
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.